US Stock MarketDetailed Quotes

ENGN enGene Holdings

Watchlist

5.240
-0.010-0.19%

Close Mar 10 16:00 ET

267.12MMarket Cap-3.87P/E (TTM)

enGene Holdings Stock Forum

Teddy123

6 hours ago

enGene Reports First Quarter 2025 Financial Results and Provides Business Update

$enGene Holdings (ENGN.US)$
enGene Reports Q1 Results: Strong Cash Position Funds Global Trial Expansion

Jaguar8

Sep 26, 2024 14:52

PM NEWS

$enGene Holdings (ENGN.US)$
Detalimogene Demonstrates 71% Complete Response Rate at Any Time in Preliminary Analysis of LEGEND Pivotal Cohort
Data from pivotal cohort demonstrate compelling clinical activity, consistent with Phase 1 results
Favorable tolerability profile with no drug-related discontinuations
Detalimogene's profile to date supports its potential as a foundational therapy for NMIBC
enGene to host a conference call to discuss preliminary data today at 8:00 a.m. ET
enGene Hold...

Mcsnacks H Tupack

Aug 2, 2024 13:53

Stocks getting near their bounce price

$Pop Culture (CPOP.US)$
$Aptevo Therapeutics (APVO.US)$
$enGene Holdings (ENGN.US)$
$Trxade Health (MEDS.US)$

Mcsnacks H Tupack

Jul 25, 2024 19:29

The last 2 weeks of success

The position indicator has been the most helpful the last week with so many CB(circuit breakers) happening. I have been able to enter and exit with profits of 300% this week. Last week my stocks I had been holding for a long time finally came thru and my accounts went up 300%. So since July 16th I am up 600% and not planning on stopping.
My next high risk investment is $WeBuy Global (WBUY.US)$. They have until Monday to get their stock over a 1.00 or delisting procedur...

Q2 earnings challenge: Ride the market wave with moomoo

Mcsnacks H Tupack

Jul 25, 2024 13:35

Unusual volume

$enGene Holdings (ENGN.US)$ If this is shorts covering it will run up big.

JESSE JAMES8832

Feb 25, 2024 08:46

SUPER HIGH CTB

Moomoo AI

Jan 30, 2024 06:02

The appointment of Lee Giguere, an experienced public biotech legal executive, is expected to strongly support enGene's growth as the company advances the development of EG-70 in its ongoing pivotal-stage LEGEND study in BCG-unresponsive non-muscle invasive bladder cancer.